
  
    
      
        Background_NNP
        The_DT biliary_JJ system_NN is_VBZ more_JJR than_IN a_DT passive_JJ conduit_NN
        transporting_VBG bile_NN from_IN the_DT liver_NN to_TO the_DT intestines_NNS ._. Hepatic_NNP
        bile_NN is_VBZ actively_RB modified_VBN by_IN the_DT epithelial_NN cells_NNS that_WDT line_NN
        the_DT bile_NN ducts_NNS and_CC gallbladder_NN ._. Biliary_NNP epithelial_NN function_NN
        is_VBZ partially_RB under_IN the_DT control_NN of_IN secretin_NN and_CC vasoactive_JJ
        intestinal_NN peptide_NN [_NN 1_CD ]_NN ._. Other_JJ extracellular_NN agonists_NNS
        that_WDT influence_NN biliary_JJ function_NN include_VBP neuropeptides_NNS [_NN 2_CD 3_CD
        ]_NN ,_, ATP_NNP [_NN 4_CD 5_CD ]_NN ,_, and_CC bile_NN salts_NNS [_NN 6_CD ]_NN ._. In_IN addition_NN to_TO the_DT
        well-documented_JJ role_NN that_IN cytokines_NNS play_VBP in_IN the_DT immune_JJ
        response_NN and_CC inflammation_NN [_NN 7_CD 8_CD ]_NN ,_, cytokines_NNS also_RB modify_VB
        the_DT functioning_NN of_IN epithelial_NN cells_NNS ._. For_IN instance_NN ,_, tumor_NN
        necrosis_NNS factor-α_JJ (_( TNF-α_NNP )_) can_MD modify_VB intracellular_NN signal_NN
        transduction_NN and_CC regulate_VB ionic_JJ channel_NN activities_NNS in_IN
        various_JJ epithelial_NN cells_NNS [_NN 9_CD ]_NN ._. A_DT few_JJ studies_NNS have_VBP shown_VBN
        that_IN cytokines_NNS can_MD alter_VB biliary_JJ epithelial_NN cell_NN function_NN [_NN
        10_CD 11_CD ]_NN ._.
        Biliary_NNP epithelial_NN cells_NNS are_VBP capable_JJ of_IN producing_VBG a_DT
        great_JJ variety_NN of_IN physiologically_RB active_JJ compounds_NNS ._. For_IN
        example_NN ,_, it_PRP has_VBZ been_VBN shown_VBN that_IN biliary_JJ epithelial_NN cells_NNS
        synthesize_VB nitric_JJ oxide_NN ,_, a_DT strong_JJ vasodilator_NN [_NN 12_CD ]_NN ,_, and_CC
        endothelin-_NN 1_CD [_NN 13_CD ]_NN ,_, a_DT potent_JJ vasoconstrictor_NN ._. Various_JJ
        cytokines_NNS are_VBP also_RB produced_VBN by_IN biliary_JJ epithelial_NN cells_NNS [_NN
        14_CD ]_NN ._. As_IN biliary_JJ epithelial_NN cells_NNS are_VBP capable_JJ of_IN both_DT
        producing_VBG and_CC responding_VBG to_TO cytokines_NNS ,_, these_DT cells_NNS may_MD use_VB
        cytokines_NNS for_IN the_DT autocrine_NN /_NN paracrine_NN regulation_NN of_IN their_PRP$
        own_JJ function_NN as_RB well_RB as_IN that_DT of_IN other_JJ cells_NNS ._.
        Bile_NNP in_IN the_DT biliary_JJ ducts_NNS and_CC the_DT gallbladder_NN often_RB
        contains_VBZ bacteria_NNS and_CC the_DT bacterial_JJ product_NN
        lipopolysaccharide_NN (_( LPS_NNP )_) ._. This_DT may_MD be_VB due_JJ to_TO ascending_VBG
        infection_NN from_IN the_DT intestine_NN or_CC descending_VBG infection_NN via_IN
        portal_NN venous_JJ blood_NN [_NN 15_CD 16_CD ]_NN ._. Bacterial_NNP infection_NN usually_RB
        leads_VBZ to_TO activation_NN of_IN the_DT immune_JJ system_NN followed_VBN by_IN
        inflammation_NN ._. While_IN inflammation_NN is_VBZ an_DT important_JJ element_NN in_IN
        the_DT defense_NN against_IN infection_NN ,_, it_PRP can_MD also_RB contribute_VB to_TO
        cholestatic_JJ biliary_JJ diseases_NNS and_CC cholelithiasis_NNS ._. Therefore_RB ,_,
        the_DT control_NN of_IN the_DT immune_JJ and_CC inflammatory_JJ response_NN of_IN
        biliary_JJ tissue_NN to_TO bacteria_NNS is_VBZ important_JJ in_IN determining_VBG
        disease_NN progression_NN ._. While_IN the_DT biliary_JJ epithelium_NN can_MD act_VB
        as_IN a_DT physical_JJ barrier_NN to_TO limit_VB bacterial_JJ infection_NN of_IN the_DT
        underlying_VBG tissue_NN [_NN 16_CD ]_NN ,_, its_PRP$ physiological_JJ response_NN to_TO
        bacteria_NNS and_CC bacterial_JJ products_NNS is_VBZ not_RB well_RB characterized_VBN ._.
        Like_IN pulmonary_JJ and_CC intestinal_NN epithelial_NN cells_NNS ,_, biliary_JJ
        epithelial_NN cells_NNS might_MD respond_VB to_TO bacteria_NNS in_IN bile_NN by_IN
        producing_VBG cytokines_NNS and_CC other_JJ factors_NNS ._. To_TO test_VB this_DT
        hypothesis_NNS ,_, we_PRP used_VBD cultured_JJ normal_JJ mouse_NN gallbladder_NN
        epithelial_NN cells_NNS (_( MGBE_NNP )_) as_IN an_DT 
        in_IN vitro_NN model_NN system_NN to_TO examine_VB the_DT
        ability_NN of_IN gallbladder_NN epithelium_NN to_TO produce_VB mRNA_NN for_IN
        various_JJ cytokines_NNS and_CC chemokines_NNS ._. The_DT synthesis_NN and_CC
        secretion_NN of_IN TNF-α_NNP protein_NN was_VBD also_RB measured_VBN ._. These_DT cells_NNS
        demonstrated_VBD distinct_JJ changes_NNS in_IN their_PRP$ cytokine_NN and_CC
        chemokine_NN mRNA_NN expression_NN profile_NN and_CC TNF-α_NNP protein_NN
        production_NN in_IN response_NN to_TO LPS_NNP ._.
      
      
        Methods_NNP
        
          Materials_NNS
          Analytical_NNP grade_NN chemicals_NNS and_CC tissue_NN culture_NN supplies_NNS
          were_VBD obtained_VBN from_IN Sigma_NNP Chemical_NNP Co_NNP ._. (_( St_NNP ._. Louis_NNP ,_, MO_NNP )_) ,_,
          except_IN where_WRB noted_VBD ._. Vitrogen_NNP (_( bovine_JJ dermal_NN collagen_NN )_) was_VBD
          purchased_VBN from_IN Collagen_NNP Corp_NNP ._. (_( Palo_NNP Alto_NNP ,_, CA_NNP )_) ._. Transwell_NNP
          inserts_NNS (_( 24_CD mm_NN diameter_NN ,_, 3_CD μm_NN pore_NN size_NN )_) were_VBD purchased_VBN
          from_IN Corning_NNP Corp_NNP ._. (_( Acton_NNP ,_, MA_NNP )_) ._.
        
        
          Cell_NNP culture_NN
          MGBE_NNP were_VBD grown_VBN as_RB previously_RB described_VBD [_NN 17_CD ]_NN ._. In_IN
          brief_JJ ,_, MGBE_NNP were_VBD grown_VBN on_IN Vitrogen-coated_NNP Transwell_NNP
          inserts_NNS suspended_VBN above_IN human_JJ gallbladder_NN myo-fibroblast_JJ
          feeder_NN cells_NNS ._. The_DT cells_NNS were_VBD fed_VBN with_IN Eagle_NNP 's_POS minimum_JJ
          essential_JJ medium_NN containing_VBG 10_CD %_NN fetal_JJ bovine_JJ serum_NN ,_, 2_CD mM_NN
          L-_NNP glutamine_NN ,_, 20_CD mM_NN HEPES_NNP ,_, 100_CD IU_NNP /_NN mL_NN penicillin_NN ,_, 100_CD μg_NN /_NN mL_NN
          streptomycin_NN ,_, plus_CC Insulin-_NNP Transferrin-_NNP Sodium_NNP Selenite_NNP
          Media_NNP Supplement_NNP ,_, MEM-vitamins_NNP ,_, and_CC MEM-non-essential_NNP
          amino_JJ acid_NN solution_NN (_( Sigma_NNP Chemical_NNP Co_NNP ._. )_) ._. Confluent_NNP MGBE_NNP
          have_VBP well-differentiated_JJ morphology_NN and_CC high_JJ
          transepithelial_NN electrical_JJ resistance_NN (_( 163_CD Ω_NN /_NN cm_NN 2_LS )_) [_NN 17_CD ]_NN
          ._. Prior_RB to_TO each_DT experiment_NN ,_, Transwell_NNP inserts_NNS with_IN
          confluent_NN MGBE_NNP were_VBD transferred_VBN to_TO new_JJ plates_NNS without_IN
          feeder_NN cells_NNS ._.
        
        
          RT-PCR_NNP assay_NN of_IN cytokine_NN and_CC chemokine_NN mRNA_NN
          Confluent_NNP MGBE_NNP were_VBD fed_VBN serum-free_JJ medium_NN ._. Cells_NNP were_VBD
          treated_VBN with_IN LPS_NNP from_IN 
          E_NNP ._. coli_NNS (_( serotype_NN 0111_CD :_: B_NNP 4_LS )_) or_CC 
          Pseudomonas_NNP aeruginosa_NN (_( serotype_NN
          10_CD )_) at_IN 100_CD μg_NN /_NN mL_NN ,_, added_VBD to_TO the_DT apical_JJ compartment_NN of_IN the_DT
          insert_NN ._. After_IN two_CD hours_NNS ,_, the_DT cells_NNS were_VBD harvested_VBN by_IN
          trypsinization_NN ,_, and_CC total_JJ RNA_NNP was_VBD extracted_VBN using_VBG TRIzol_NNP
          reagent_NN (_( Gibco_NNP BRL_NNP ,_, Gaithersburg_NNP ,_, MD_NNP )_) ._. Five_CD μg_NN of_IN total_JJ
          RNA_NNP was_VBD reverse-transcribed_JJ according_VBG to_TO the_DT
          manufacturer_NN 's_POS protocol_NN (_( Superscript_NNP II_NNP Preamplification_NNP
          System_NNP ,_, Gibco_NNP BRL_NNP )_) using_VBG oligo_NN (_( dT_NN )_) as_IN primer_NN ._. cDNA_NN
          prepared_VBN from_IN 0_CD ._. 5_CD μg_NN RNA_NNP was_VBD subjected_VBN to_TO PCR_NNP using_VBG
          murine_NN gene-specific_JJ primers_NNS for_IN 8_CD different_JJ cytokines_NNS
          and_CC chemokines_NNS (_( Table_NNP 1_LS )_) as_RB previously_RB detailed_JJ [_NN 18_CD ]_NN ._.
          All_DT of_IN the_DT primer_NN pairs_NNS spanned_VBD at_IN least_JJS one_CD intron_NN in_IN
          the_DT corresponding_JJ genomic_JJ DNA_NNP ._. Positive_JJ RNA_NNP controls_NNS were_VBD
          performed_VBN previously_RB to_TO confirm_VB specificity_NN of_IN primer_NN
          pairs_NNS (_( data_NNS not_RB shown_VBN )_) ._. Negative_JJ controls_NNS were_VBD performed_VBN
          by_IN omitting_VBG the_DT RT_NNP step_NN or_CC the_DT cDNA_NN template_NN from_IN PCR_NNP
          amplification_NN ._. For_IN qualitative_JJ PCR_NNP ,_, target_NN sequences_NNS were_VBD
          amplified_VBN at_IN 56_CD °_NN C_NNP for_IN 25_CD cycles_NNS ;_: for_IN semi-quantitative_JJ
          PCR_NNP ,_, target_NN sequences_NNS for_IN TNF-α_NNP ,_, IL-_NNP 1_CD β_NN ,_, and_CC MIP-_NNP 2_CD (_( CXCL_NNP 2_LS )_)
          were_VBD amplified_VBN at_IN 56_CD °_NN C_NNP between_IN 22_CD and_CC 32_CD cycles_NNS in_IN order_NN
          to_TO yield_VB visible_JJ products_NNS within_IN the_DT linear_JJ amplification_NN
          range_NN ._. PCR_NNP products_NNS were_VBD separated_VBN by_IN electrophoresis_NNS on_IN
          a_DT 2_CD %_NN agarose_NN gel_NN and_CC stained_JJ with_IN ethidium_NN bromide_NN ._. All_DT
          RT-PCR_NNP bands_NNS at_IN the_DT expected_VBN size_NN were_VBD also_RB directly_RB
          sequenced_JJ to_TO confirm_VB their_PRP$ identity_NN ._.
          Glyceraldehyde-_NNP 3_CD -_: phosphate_NN dehydrogenase_NN (_( GAPDH_NNP )_) or_CC
          acidic_JJ ribosomal_JJ phosphoprotein_NN (_( ARP_NNP )_) were_VBD used_VBN as_IN
          internal_JJ controls_NNS ._.
        
        
          TNF-α_NNP Immunoassay_NNP
          Confluent_NNP MGBE_NNP were_VBD fed_VBN serum-free_JJ medium_NN ,_, with_IN or_CC
          without_IN LPS_NNP added_VBD to_TO the_DT apical_JJ side_NN (_( LPS_NNP concentration_NN =_SYM
          2_CD or_CC 100_CD μg_NN /_NN mL_NN )_) ._. Medium_NNP from_IN the_DT apical_JJ and_CC basolateral_NN
          compartment_NN was_VBD collected_VBN separately_RB at_IN measured_VBN
          intervals_NNS and_CC immediately_RB frozen_VBN at_IN -_: 70_CD °_NN C_NNP ._. The_DT cells_NNS were_VBD
          lysed_JJ with_IN 1_CD %_NN NP-_NNP 40_CD buffer_NN (_( 150_CD mM_NN NaCl_NNP ,_, 50_CD mM_NN Tris_NNP ,_, pH_NN
          8_CD ._. 0_CD )_) containing_VBG 100_CD μg_NN /_NN mL_NN phenylmethylsulfonyl_NN fluoride_NN
          and_CC 1_CD μg_NN /_NN mL_NN aprotinin_NN ,_, sonicated_JJ for_IN 30_CD seconds_NNS ,_, then_RB
          frozen_VBN ._. TNF-α_NNP was_VBD measured_VBN in_IN cell_NN lysate_NN and_CC undiluted_JJ
          medium_NN using_VBG the_DT Mouse_NNP TNF-α_NNP Immunoassay_NNP Kit_NNP from_IN R_NN &_CC D_NNP
          Systems_NNPS (_( Minneapolis_NNP ,_, MN_NNP )_) ._. Statistical_NNP analysis_NN on_IN the_DT
          TNF-α_NNP immunoassay_NN data_NNS was_VBD performed_VBN using_VBG Student_NNP 's_POS
          t-test_JJ ._. Cell_NNP viability_NN was_VBD assessed_VBN by_IN measuring_VBG lactate_NN
          dehydrogenase_NN release_NN into_IN the_DT medium_NN ,_, as_RB previously_RB
          described_VBD [_NN 6_CD ]_NN ._. Changes_NNS in_IN transepithelial_NN permeability_NN
          was_VBD measured_VBN using_VBG 3_CD H-_NNP mannitol_NN as_IN a_DT small_JJ molecular_JJ
          weight_NN probe_NN ._. Tritiated_NNP mannitol_NN (_( 2_CD μCi_NN )_) with_IN cold_JJ
          mannitol_NN (_( 0_CD ._. 15_CD mM_NN )_) was_VBD added_VBN to_TO the_DT apical_JJ medium_NN and_CC
          samples_NNS of_IN the_DT basolateral_NN medium_NN harvested_VBN and_CC counted_VBN
          at_IN 1_CD ,_, 2_CD ,_, 4_CD ,_, and_CC 24_CD hours_NNS after_IN LPS_NNP treatment_NN ._.
        
      
      
        Results_NNS
        
          RT-PCR_NNP
          Using_VBG cytokine_NN /_NN chemokine-specific_JJ primers_NNS with_IN RT-PCR_NNP ,_,
          untreated_JJ MGBE_NNP showed_VBD distinct_JJ bands_NNS representing_VBG mRNA_NN of_IN
          TNF-α_NNP ,_, RANTES_NNP (_( Regulated_NNP on_IN activation_NN ,_, normal_JJ T_NN cell_NN
          expressed_VBD and_CC secreted_JJ )_) (_( CCL_NNP 5_LS )_) ,_, and_CC macrophage_NN
          inflammatory_JJ protein-_NN 2_CD (_( MIP-_NNP 2_CD /_NN CXCL_NNP 2_LS )_) (_( Figure_NN 1_LS )_) ._. Upon_IN
          apical_JJ treatment_NN with_IN LPS_NNP from_IN 
          E_NNP ._. coli_NNS for_IN two_CD hours_NNS ,_, these_DT cells_NNS
          additionally_RB produced_VBN mRNA_NN for_IN interleukin-_NN 1_CD β_NN (_( IL-_NNP 1_CD β_NN )_) ,_,
          IL-_NNP 6_CD ,_, and_CC monocyte_NN chemoattractant_NN protein-_NN 1_CD
          (_( MCP-_NNP 1_CD /_NN CCL_NNP 2_LS )_) ._. There_EX was_VBD no_DT detectable_JJ expression_NN of_IN IL-_NNP 10_CD
          or_CC KC_NNP (_( murine_NN GRO-α_NNP /_NN CXCL_NNP 1_LS )_) mRNA_NN before_IN or_CC after_IN LPS_NNP
          treatment_NN ._. Semi-quantitative_NNP RT-PCR_NNP using_VBG specific_JJ
          primers_NNS for_IN TNF-α_NNP ,_, MIP-_NNP 2_CD (_( CXCL_NNP 2_LS )_) and_CC IL-_NNP 1_CD β_NN showed_VBD that_IN
          LPS_NNP treatment_NN caused_VBD the_DT amount_NN of_IN TNF-α_NNP mRNA_NN to_TO slightly_RB
          increase_VB compared_VBN to_TO the_DT already_RB abundant_JJ levels_NNS found_VBD in_IN
          untreated_JJ cells_NNS (_( figure_NN 2_CD and_CC 3_LS )_) ._. In_IN contrast_NN ,_, there_EX was_VBD a_DT
          substantial_JJ increase_NN in_IN the_DT expression_NN of_IN MIP-_NNP 2_CD (_( CXCL_NNP 2_LS )_)
          mRNA_NN and_CC IL-_NNP 1_CD β_NN mRNA_NN following_VBG LPS_NNP treatment_NN compared_VBN to_TO
          control_VB ._. Similar_JJ responses_NNS were_VBD seen_VBN when_WRB the_DT cells_NNS were_VBD
          treated_VBN with_IN LPS_NNP from_IN 
          P_NN ._. aeruginosa_NN (_( Figure_NN 2_CD and_CC 3_LS )_) ._. All_DT
          visualized_JJ PCR_NNP product_NN bands_NNS were_VBD of_IN the_DT expected_VBN size_NN
          and_CC nucleotide_NN sequence_NN confirming_VBG proper_JJ identification_NN ._.
          Although_IN the_DT RANTES_NNP (_( CCL_NNP 5_LS )_) sample_NN had_VBD extra_JJ bands_NNS of_IN
          unknown_JJ origin_NN ,_, the_DT band_NN at_IN the_DT expected_VBN size_NN of_IN 205_CD bp_NN
          had_VBD a_DT nucleotide_NN sequence_NN that_WDT matched_VBD RANTES_NNP ._.
        
        
          TNF-α_NNP Immunoassay_NNP
          The_DT immunoassay_NN experiments_NNS showed_VBD no_DT detectable_JJ TNF-α_NNP
          in_IN untreated_JJ MGBE_NNP or_CC their_PRP$ surrounding_VBG media_NNS after_IN 5_CD
          hours_NNS of_IN incubation_NN (_( limit_NN of_IN detection_NN =_SYM 5_CD ._. 1_CD pg_NN /_NN mL_NN )_) ._. In_IN
          contrast_NN ,_, following_VBG treatment_NN with_IN 100_CD μg_NN /_NN mL_NN 
          E_NNP ._. coli_NNS LPS_NNP the_DT concentration_NN of_IN
          TNF-α_NNP protein_NN in_IN the_DT cells_NNS was_VBD 33_CD ._. 6_CD pg_NN per_IN 10_CD 6_CD cells_NNS in_IN
          one_CD hour_NN (_( Figure_NN 4_LS )_) ._. Intracellular_NNP TNF-α_NNP concentration_NN
          reached_VBD a_DT peak_NN two_CD hours_NNS after_IN LPS_NNP treatment_NN with_IN a_DT
          subsequent_JJ decrease_NN by_IN five_CD hours_NNS ._. After_IN two_CD and_CC five_CD
          hours_NNS of_IN LPS_NNP treatment_NN ,_, there_EX was_VBD measurable_JJ release_NN of_IN
          TNF-α_NNP into_IN the_DT media_NNS of_IN both_DT the_DT apical_JJ and_CC basolateral_NN
          compartments_NNS (_( figure_NN 5_LS )_) ._. Three_CD different_JJ species_NNS of_IN LPS_NNP (_(
          
          E_NNP ._. coli_NNS ,_, 
          P_NN ._. aeruginosa_NN ,_, and_CC 
          Klebsiella_NNP pneumoniae_NN )_) stimulated_VBN
          TNF-α_NNP release_NN in_IN a_DT similar_JJ fashion_NN (_( figure_NN 6_CD )_) ._. Treatment_NNP
          with_IN 2_CD μg_NN /_NN mL_NN 
          E_NNP ._. coli_NNS LPS_NNP showed_VBD comparable_JJ
          results_NNS ._. None_NN of_IN the_DT treatments_NNS increased_VBD lactate_NN
          dehydrogenase_NN in_IN the_DT medium_NN compared_VBN with_IN controls_NNS
          showing_VBG that_IN the_DT LPS_NNP treatments_NNS did_VBD not_RB alter_VB epithelial_NN
          cell_NN integrity_NN (_( data_NNS not_RB shown_VBN )_) ._. LPS_NNP treatment_NN also_RB had_VBD
          no_DT effect_NN on_IN the_DT transepithelial_NN permeability_NN of_IN these_DT
          cells_NNS for_IN up_IN to_TO 24_CD hours_NNS as_IN measured_VBN by_IN 3_CD H-_NNP mannitol_NN
          diffusion_NN experiments_NNS when_WRB compared_VBN to_TO controls_NNS (_( data_NNS not_RB
          shown_VBN )_) ._.
        
      
      
        Discussion_NNP
        Bacteria_NNP are_VBP found_VBN in_IN the_DT bile_NN of_IN the_DT gallbladder_NN and_CC
        bile_NN ducts_NNS [_NN 15_CD 16_CD ]_NN ,_, the_DT presence_NN of_IN which_WDT may_MD have_VB
        relevance_NN to_TO clinical_JJ diseases_NNS such_JJ as_IN stone_NN formation_NN [_NN 19_CD
        20_CD 21_CD ]_NN ,_, primary_JJ sclerosing_VBG cholangitis_NNS [_NN 22_CD ]_NN ,_, and_CC
        cholestasis_NNS [_NN 23_CD 24_CD ]_NN ._. Direct_NNP exposure_NN of_IN sub-epithelial_JJ
        tissue_NN to_TO LPS_NNP from_IN gram-negative_JJ bacteria_NNS causes_NNS release_NN of_IN
        cytokines_NNS by_IN resident_NN leukocytes_NNS and_CC activation_NN of_IN
        macrophages_NNS [_NN 25_CD ]_NN ._. The_DT biliary_JJ fluid_NN of_IN patients_NNS with_IN
        cholangitis_NNS has_VBZ increased_VBN concentrations_NNS of_IN the_DT
        inflammatory_JJ cytokines_NNS TNF-α_NNP and_CC IL-_NNP 6_CD suggesting_VBG that_IN
        bacterial_JJ infection_NN leads_VBZ to_TO an_DT increase_NN in_IN cytokines_NNS
        released_VBN into_IN the_DT bile_NN [_NN 26_CD ]_NN ._. Adding_VBG LPS_NNP to_TO the_DT bile_NN of_IN
        guinea_NN pig_NN gallbladders_NNS 
        in_IN vivo_NN led_VBN to_TO increased_VB IL-_NNP 1_CD
        concentration_NN in_IN the_DT bile_NN [_NN 27_CD ]_NN ._. What_WP role_NN biliary_JJ
        epithelial_NN cells_NNS play_VBP in_IN the_DT response_NN to_TO bacteria_NNS in_IN bile_NN
        is_VBZ not_RB known_VBN ._.
        While_IN most_JJS cytokine_NN research_NN has_VBZ focused_VBN on_IN cells_NNS of_IN the_DT
        immune_JJ system_NN ,_, other_JJ cell_NN types_NNS produce_VBP cytokines_NNS including_VBG
        the_DT epithelial_NN cells_NNS of_IN the_DT lung_NN [_NN 28_CD 29_CD ]_NN ,_, retina_NN [_NN 30_CD ]_NN
        ,_, and_CC intestines_NNS [_NN 31_CD 32_CD ]_NN ._. Among_IN the_DT few_JJ studies_NNS
        involving_VBG the_DT biliary_JJ system_NN ,_, it_PRP was_VBD demonstrated_VBN that_IN
        cultured_JJ human_JJ intrahepatic_JJ duct_NN epithelial_NN cells_NNS produce_VBP
        functional_JJ IL-_NNP 8_CD and_CC MCP-_NNP 1_CD (_( CCL_NNP 2_LS )_) [_NN 14_CD 33_CD ]_NN ._. Isolated_NNP human_JJ
        intrahepatic_JJ epithelial_NN ducts_NNS expressed_VBD immunoreactive_JJ IL-_NNP 6_CD
        when_WRB treated_VBN with_IN IL-_NNP 1_CD β_NN or_CC phorbal_NN myristate_NN acetate_NN [_NN 34_CD ]_NN
        ._. Intracellular_NNP TNF-α_NNP mRNA_NN and_CC protein_NN was_VBD detected_VBN in_IN
        intrahepatic_JJ biliary_JJ duct_NN cells_NNS in_IN tissue_NN sections_NNS [_NN 35_CD ]_NN ,_,
        but_CC not_RB in_IN cultured_JJ intrahepatic_JJ epithelial_NN cells_NNS ;_:
        therefore_RB ,_, there_EX was_VBD no_DT clear_JJ demonstration_NN that_IN biliary_JJ
        epithelium_NN secretes_NNS TNF-α_NNP ._. Little_JJ research_NN has_VBZ focused_VBN on_IN
        the_DT ability_NN of_IN the_DT epithelial_NN cells_NNS of_IN the_DT extrahepatic_JJ
        biliary_JJ system_NN to_TO produce_VB cytokines_NNS or_CC chemokines_NNS ._.
        As_IN described_VBD in_IN this_DT paper_NN ,_, MGBE_NNP were_VBD used_VBN as_IN an_DT 
        in_IN vitro_NN model_NN system_NN of_IN gallbladder_NN
        epithelium_NN to_TO measure_VB the_DT endogenous_JJ production_NN of_IN
        cytokines_NNS and_CC chemokines_NNS by_IN extrahepatic_JJ biliary_JJ epithelial_NN
        cells_NNS ._. These_DT cultured_JJ cells_NNS consist_VBP exclusively_RB of_IN normal_JJ ,_,
        non-neoplastic_JJ epithelial_NN cells_NNS [_NN 17_CD ]_NN ,_, without_IN other_JJ cell_NN
        types_NNS such_JJ as_IN leukocytes_NNS ordinarily_RB found_VBD in_IN biliary_JJ
        tissues_NNS ._. The_DT experiments_NNS showed_VBD that_IN unstimulated_JJ MGBE_NNP
        express_VB mRNA_NN for_IN TNF-α_NNP ,_, MIP-_NNP 2_CD ,_, and_CC RANTES_NNP (_( CCL_NNP 5_LS )_) ._. After_IN
        treating_VBG the_DT apical_JJ surface_NN of_IN the_DT cells_NNS with_IN LPS_NNP ,_, the_DT mRNA_NN
        levels_NNS for_IN TNF-α_NNP and_CC MIP-_NNP 2_CD (_( CXCL_NNP 2_LS )_) increased_VBN ,_, while_IN mRNA_NN
        for_IN IL-_NNP 1_CD β_NN ,_, IL-_NNP 6_CD ,_, and_CC MCP-_NNP 1_CD (_( CCL_NNP 2_LS )_) appeared_VBD for_IN the_DT first_JJ
        time_NN ._. Therefore_RB ,_, cytokines_NNS (_( TNF-α_NNP ,_, IL-_NNP 1_CD β_NN ,_, and_CC IL-_NNP 6_CD )_) ,_, a_DT C-C_NNP
        type_NN chemokine_NN (_( MCP-_NNP 1_CD /_NN CCL_NNP 2_LS )_) ,_, and_CC a_DT C-X-C_NNP type_NN chemokine_NN
        (_( MIP-_NNP 2_CD /_NN CXCL_NNP 2_LS )_) are_VBP all_DT up_RB regulated_VBN at_IN the_DT RNA_NNP level_NN by_IN
        bacterial_JJ product_NN interaction_NN with_IN the_DT epithelial_NN cells_NNS ._.
        The_DT effects_NNS of_IN LPS_NNP treatment_NN for_IN two_CD hours_NNS on_IN cytokine_NN and_CC
        chemokine_NN mRNA_NN expression_NN clearly_RB suggests_VBZ that_IN biliary_JJ
        epithelial_NN cells_NNS can_MD modify_VB their_PRP$ own_JJ cytokine_NN and_CC
        chemokine_NN production_NN after_IN bacterial_JJ challenge_NN at_IN the_DT mRNA_NN
        level_NN ._. As_IN with_IN all_DT 
        in_IN vitro_NN cell_NN systems_NNS there_RB is_VBZ the_DT
        possibility_NN that_IN the_DT cells_NNS in_IN culture_NN may_MD have_VB phenotypic_JJ
        changes_NNS to_TO their_PRP$ cytokine_NN profile_NN compared_VBN to_TO 
        in_IN vivo_NN cells_NNS ._. In_IN other_JJ parameters_NNS
        tested_VBN (_( i_NNP ._. e_SYM ._. ,_, morphology_NN ,_, mucin_NN secretion_NN ,_, etc_FW ._. )_) ,_, these_DT
        cells_NNS retain_VBP the_DT normal_JJ phenotype_NN of_IN cells_NNS 
        in_IN vivo_NN ._.
        Measurements_NNP of_IN TNF-α_NNP protein_NN showed_VBD that_IN MGBE_NNP
        synthesize_VB and_CC secrete_NN TNF-α_NNP when_WRB exposed_VBN to_TO LPS_NNP ,_, while_IN
        untreated_JJ cells_NNS do_VBP not_RB ._. This_DT demonstrates_VBZ that_DT gallbladder_NN
        epithelial_NN cells_NNS themselves_PRP secrete_NN a_DT cytokine_NN in_IN response_NN
        to_TO bacterial_JJ products_NNS ._. The_DT results_NNS from_IN RT-PCR_NNP (_( showing_VBG a_DT
        relatively_RB high_JJ TNF-α_NNP mRNA_NN expression_NN levels_NNS in_IN untreated_JJ
        cells_NNS which_WDT is_VBZ only_RB slightly_RB increased_VBN by_IN LPS_NNP treatment_NN )_)
        along_IN with_IN the_DT immunoassay_NN results_NNS suggest_VBP that_IN TNF-α_NNP mRNA_NN
        is_VBZ constantly_RB present_JJ in_IN these_DT cells_NNS ,_, but_CC is_VBZ not_RB translated_VBN
        into_IN protein_NN until_IN certain_JJ triggers_VBZ are_VBP provided_VBN ._. This_DT is_VBZ
        consistent_JJ with_IN the_DT post-transcriptional_JJ regulation_NN of_IN
        TNF-α_NNP observed_VBD in_IN other_JJ cells_NNS [_NN 36_CD ]_NN ._. In_IN contrast_NN ,_, the_DT
        mRNA_NN of_IN other_JJ factors_NNS ,_, such_JJ as_IN IL-_NNP 1_CD β_NN ,_, IL-_NNP 6_CD ,_, and_CC MCP-_NNP 1_CD
        (_( CCL_NNP 2_LS )_) are_VBP not_RB synthesized_JJ until_IN the_DT cells_NNS are_VBP stimulated_VBN ,_,
        suggesting_VBG that_IN their_PRP$ production_NN is_VBZ under_IN transcriptional_NN
        control_NN ._. The_DT protein_NN expression_NN of_IN these_DT other_JJ cytokines_NNS
        and_CC chemokines_NNS along_IN with_IN the_DT precise_JJ nature_NN of_IN the_DT
        interaction_NN between_IN LPS_NNP and_CC cell_NN surface_NN receptors_NNS warrants_NNS
        further_JJ study_NN ._.
        While_IN the_DT exact_JJ role_NN that_DT gallbladder_NN epithelial_NN cells_NNS
        play_VBP in_IN inflammatory_JJ and_CC infectious_JJ diseases_NNS has_VBZ yet_RB to_TO be_VB
        determined_VBN ,_, our_PRP$ research_NN supports_VBZ the_DT hypothesis_NNS that_WDT
        gallbladder_NN epithelium_NN have_VBP some_DT innate_JJ cytokine-producing_JJ
        capabilities_NNS in_IN response_NN to_TO the_DT presence_NN of_IN bacteria_NNS on_IN
        their_PRP$ apical_JJ surface_NN ._. The_DT accumulation_NN of_IN TNF-α_NNP in_IN the_DT
        gallbladder_NN bile_NN of_IN patients_NNS with_IN cholangitis_NNS may_MD be_VB due_JJ in_IN
        part_NN to_TO the_DT apical_JJ release_NN of_IN TNF-α_NNP by_IN biliary_JJ epithelial_NN
        cells_NNS ._. In_IN contrast_NN ,_, basolateral_NN secretion_NN of_IN TNF-α_NNP could_MD
        lead_VB to_TO a_DT focal_JJ accumulation_NN of_IN TNF-α_NNP in_IN the_DT sub-mucosa_JJ of_IN
        biliary_JJ tissue_NN ._. Sufficient_NNP cytokine_NN secretion_NN could_MD then_RB
        stimulate_VB the_DT leukocytes_NNS in_IN the_DT sub-epithelial_JJ tissue_NN ,_,
        leading_VBG to_TO inflammation_NN of_IN the_DT tissue_NN ,_, without_IN the_DT need_NN for_IN
        the_DT bacteria_NNS to_TO pass_VB through_IN the_DT epithelial_NN barrier_NN ._. The_DT
        production_NN of_IN cytokines_NNS by_IN gallbladder_NN epithelial_NN cells_NNS
        following_VBG LPS_NNP exposure_NN demonstrates_VBZ that_IN biliary_JJ epithelial_NN
        cells_NNS may_MD be_VB an_DT active_JJ partner_NN with_IN the_DT immune_JJ system_NN in_IN
        the_DT detection_NN of_IN and_CC defense_NN against_IN bacteria_NNS in_IN bile_NN ._.
        During_IN sepsis_NN ,_, biliary_JJ epithelial_NN cells_NNS could_MD mediate_VB
        biliary_JJ secretory_NN function_NN through_IN cytokine_NN and_CC chemokine_NN
        production_NN ._. Dog_NNP gallbladder_NN epithelial_NN cells_NNS demonstrated_VBN
        increased_VBN mucin_NN secretion_NN following_VBG TNF-α_NNP treatment_NN [_NN 10_CD ]_NN
        ._. In_IN addition_NN ,_, exogenous_JJ TNF-α_NNP altered_VBD the_DT absorptive_JJ
        properties_NNS of_IN cultured_JJ human_JJ gallbladder_NN epithelial_NN cells_NNS [_NN
        37_CD ]_NN ._. It_PRP is_VBZ therefore_RB reasonable_JJ to_TO suggest_VB that_IN TNF-α_NNP
        produced_VBN by_IN gallbladder_NN epithelial_NN cells_NNS in_IN response_NN to_TO LPS_NNP
        could_MD affect_VB cellular_JJ function_NN in_IN an_DT autocrine_NN manner_NN ._.
        Since_IN mucin_NN secretion_NN and_CC gallbladder_NN transport_NN properties_NNS
        play_VBP vital_JJ roles_NNS in_IN cholelithiasis_NNS ,_, changes_NNS in_IN these_DT
        parameters_NNS caused_VBN by_IN endogenous_JJ cytokines_NNS and_CC chemokines_NNS
        may_MD promote_VB stone_NN formation_NN ._. Epithelial-derived_NNP cytokines_NNS
        and_CC chemokines_NNS also_RB may_MD alter_VB biliary_JJ function_NN leading_VBG to_TO
        cholestasis_NNS ._.
      
      
        Conclusions_NNP
        Gallbladder_NNP epithelial_NN cells_NNS demonstrated_VBD distinct_JJ
        patterns_NNS of_IN expression_NN of_IN mRNA_NN for_IN various_JJ cytokines_NNS and_CC
        chemokines_NNS ,_, and_CC responded_VBD to_TO treatment_NN with_IN LPS_NNP by_IN altering_VBG
        their_PRP$ expression_NN of_IN certain_JJ cytokine_NN and_CC chemokine_NN RNA_NNP and_CC
        increasing_VBG TNF-α_NNP protein_NN synthesis_NN and_CC secretion_NN ._. The_DT
        ability_NN of_IN biliary_JJ epithelial_NN cell_NN to_TO control_VB endogenous_JJ
        cytokine_NN and_CC chemokine_NN production_NN has_VBZ important_JJ
        implications_NNS for_IN biliary_JJ inflammation_NN and_CC diseases_NNS ,_, such_JJ as_IN
        cholangitis_NNS ,_, cholestasis_NNS ,_, and_CC cholelithiasis_NNS ._.
      
      
        Competing_VBG interests_NNS
        None_NN declared_VBD ._.
      
      
        Authors_NNP '_'' contributions_NNS
        CES_NNP participated_VBD in_IN the_DT design_NN and_CC coordination_NN of_IN the_DT
        study_NN ,_, performed_VBD the_DT immunoassay_NN studies_NNS ,_, and_CC drafted_VBD the_DT
        manuscript_NN ._. TAB_NNP performed_VBD the_DT RT-PCR_NNP studies_NNS ._. H-SC_NNP assisted_VBN
        in_IN the_DT immunoassay_NN studies_NNS ._. S-KL_NNP initiated_VBD the_DT immunoassay_NN
        studies_NNS ._. SJP_NNP participated_VBD in_IN the_DT design_NN of_IN the_DT RT-PCR_NNP
        studies_NNS ._. SPL_NNP conceived_VBD of_IN the_DT study_NN ,_, and_CC participated_VBD in_IN
        its_PRP$ design_NN and_CC coordination_NN ._.
      
      
        Abbreviations_NNP
        IL_NNP (_( Interleukin_NNP )_) ,_, LPS_NNP (_( Lipopolysaccharides_NNP )_) ,_, MCP-_NNP 1_CD
        (_( Monocyte_NNP chemoattractant_NN protein-_NN 1_LS )_) ,_, MGBE_NNP (_( Mouse_NNP
        gallbladder_NN epithelial_NN cells_NNS )_) ,_, MIP-_NNP 2_CD (_( Macrophage_NNP
        inflammatory_JJ protein-_NN 2_LS )_) ,_, RANTES_NNP (_( Regulated_NNP on_IN activation_NN ,_,
        normal_JJ T_NN cell_NN expressed_VBD and_CC secreted_JJ )_) ,_, TNF-α_NNP (_( Tumor_NNP
        Necrosis_NNP Factor-alpha_NNP )_) ._.
      
    
  
